Article Versions Notes

Bahouth F, Chutko B, Sholy H, Hassanain S, Zaid G, Radzishevsky E, Fahmwai I, Hamoud M, Samnia N, Khoury J, et al. Ticagrelor Versus Prasugrel in Acute Coronary Syndrome: Real-World Treatment and Safety. Medicines. 2025; 12(2):13. https://doi.org/10.3390/medicines12020013

Bahouth, Fadel, Boris Chutko, Haitham Sholy, Sabreen Hassanain, Gassan Zaid, Evgeny Radzishevsky, Ibrahem Fahmwai, Mahmod Hamoud, Nemer Samnia, Johad Khoury, and et al. 2025. "Ticagrelor Versus Prasugrel in Acute Coronary Syndrome: Real-World Treatment and Safety" Medicines 12, no. 2: 13. https://doi.org/10.3390/medicines12020013

Bahouth, F., Chutko, B., Sholy, H., Hassanain, S., Zaid, G., Radzishevsky, E., Fahmwai, I., Hamoud, M., Samnia, N., Khoury, J., & Dobrecky-Mery, I. (2025). Ticagrelor Versus Prasugrel in Acute Coronary Syndrome: Real-World Treatment and Safety. Medicines, 12(2), 13. https://doi.org/10.3390/medicines12020013